← hubDrugs

Bufotenin

Discover related

2 sources

← All substances
🔗 MergedComparePsychonautWikiPharmacology

Collated from PsychonautWiki, Pharmacology. Where sources differ (e.g. dosing), Compare shows them side by side.

Sections

Also known as Bufotenin, 5-HO-DMTPW

Addiction potentialPW
not habit-forming
ToxicityPW
toxic dose is unknown
TolerancePW
full tolerance almost immediately after ingestion; half after 1 hour; baseline after 2 hours

Smoked

Route dataPsychonautWiki

ThresholdLightCommonStrongHeavy
2 mg5–20 mg20–40 mg40–60 mg60 mg+
075 mg
LightCommonStrongHeavy
Onset15–30 seconds
Come-up15–30 seconds
Peak1–5 minutes
Offset5–10 minutes
Total15–90 minutes
After-effects10–60 minutes
OnsetCome-upPeakOffset

Dangerous interactionsPW

Unsafe interactionsPW

Caution / uncertainPW

🧬 Receptor activityPH

TargetActionAffinitySource
5-hydroxytryptamine receptor 7Ki 7.943 nMCHEMBL
5-hydroxytryptamine receptor 1AKi 25.12 nMCHEMBL
5-hydroxytryptamine receptor 2CKi 70 nMCHEMBL
Rattus norvegicusKi 341 nMCHEMBL
Serotonin 2 (5-HT2) receptorKi 380 nMCHEMBL
5-hydroxytryptamine receptor 1BKi 910 nMCHEMBL
GABA-A receptor; anion channelKi 100000 nMCHEMBL
‹ PrevPage 1 / 11–7 of 7Next ›

PharmacodynamicsPH

Bufotenin is a tryptamine related to the neurotransmitter serotonin.

Pharmacokinetics

AbsorptionPH

Rapidly absorbed following intravenous administration.

MetabolismPH

Upon oral administration, bufotenine is extensively metabolized by monoamine oxidase enzymes.
Bufotenine is a known human metabolite of n,n-dimethyl-5-methoxytryptamine.

Plan when to take Bufotenin — see where onset, peak and comedown land on the clock

Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.